Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 3)

Adenoma, Islet Cell (Phase 1)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Carcinoma, Small Cell (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Esophageal Neoplasms (Phase 1)

Gastrointestinal Stromal Tumors (Phase 1)

Hyperplasia (Phase 3)

Hypersensitivity (Phase 2)

Hypoxia (Phase 1)

Kidney Neoplasms (Phase 2)

Leukemia (Phase 1)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 1)

Leukemia, Myeloid (Phase 1)

Leukemia, Myeloid, Acute (Phase 1)

Liver Neoplasms (Phase 2)

Lung Neoplasms (Phase 2)

Melanoma (Phase 2)

Multiple Myeloma (Phase 2)

Myelodysplastic Syndromes (Phase 1)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Neuroendocrine Tumors (Phase 2)

Pancreatic Neoplasms (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Prostatic Hyperplasia (Phase 3)

Sarcoma (Phase 3)

Small Cell Lung Carcinoma (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 2)